Weight loss typically follows a pattern: a modest initial drop (often partially water weight), followed by steady fat loss of 1 to 2 pounds per week at therapeutic doses
A recent Wall Street Journal article explores how recreational athletes, including runners, cyclists, and triathletes, are increasingly using GLP-1 medications to enhance performance by reducing body weight, improving endurance, and accelerating recovery
Its small-molecule candidate danuglipron showed promising efficacy, with placebo-adjusted weight reductions of 813% in Phase 2b trials
DOI:10.1161/CIRCULATIONAHA.122.059595 Las estrategias intensivas para reducir la glucosa no lograron reducir efectivamente la morbilidad y la mortalidad cardiovasculares en pacientes con diabetes con alto riesgo cardiovascular y la visin actuar para reducir riesgo cardiovascular es un abordaje intensivo y transdiciplinario de los factores de riesgo cardiovascular y la utilizacin de frmacos cardiometablicos con demostrado beneficio en reduccin de eventos cardiovascular (MACE: Infarto no fatal, ACV no falla, muerte cardiovascular) y proteccin cardiorrenal (#SGLT2i #GLP1ar)